Correlation Between Codexis and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Codexis and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codexis and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Codexis and C4 Therapeutics, you can compare the effects of market volatilities on Codexis and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codexis with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codexis and C4 Therapeutics.

Diversification Opportunities for Codexis and C4 Therapeutics

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Codexis and CCCC is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Codexis and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Codexis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codexis are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Codexis i.e., Codexis and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Codexis and C4 Therapeutics

Given the investment horizon of 90 days Codexis is expected to generate 1.88 times less return on investment than C4 Therapeutics. But when comparing it to its historical volatility, Codexis is 1.45 times less risky than C4 Therapeutics. It trades about 0.12 of its potential returns per unit of risk. C4 Therapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  140.00  in C4 Therapeutics on April 19, 2025 and sell it today you would earn a total of  92.00  from holding C4 Therapeutics or generate 65.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Codexis  vs.  C4 Therapeutics

 Performance 
       Timeline  
Codexis 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point.
C4 Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in C4 Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, C4 Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Codexis and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Codexis and C4 Therapeutics

The main advantage of trading using opposite Codexis and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codexis position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Codexis and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets